Starfish Info
Home
The Starfish Story
Donations
Sponsors
Board of Advisors
HonoUr U
News
Association By-Laws
In the Open
Contacts
   
 
   
Starfish Projects
Autographed Items
Slow Onset Disaster
Dance4HIV
Initiatives
Events with Rutger
   
  
   
HIV/AIDS Info
Videos on AIDS
What is HIV/AIDS
4 Kidz Only
News
Day out of Days
   
 
   
LINKS
Our Friends
Rutger's Website
   
   

Scientists Use HIV Viruses and DNA Editing to Cure Deadly Childhood 'Bubble Boy Disease' in Eight Infants Left Without Immune Systems
DailyMail
Sam Blanchard
April 12, 2019


Scientists have found a way to cure children with a rare 'bubble boy disease' which leaves them without an immune system.

A total of 10 children in the US have been treated with an experimental gene therapy which made them produce vital white blood cells for the first time.

Doctors at St Jude's Children Research Hospital in Memphis, Tennessee, say they have 'cured' eight of the infants who can now live normal lives.

The altered genes used to fix the children's defective DNA were delivered into the body using damaged HIV viruses.

Experts working on the project say the breakthrough is a first for children with this rare and life-threatening illness, and say only time will tell if it's a permanent cure.

Each of the patients has X-linked severe combined immunodeficiency (SCID-X1), a condition present from birth which stops a child's immune system working.

The illness is also known as 'bubble boy disease' because patients have to be kept in isolation tanks to avoid common infections like colds, which could kill them.

'This therapy has cured the patients,' said Dr Ewelina Mamcarz, one of the study leaders. But she added only time will tell if the cure is permanent.

She said: 'These patients are toddlers now who are responding to vaccinations and have immune systems to make all immune cells they need for protection from infections as they explore the world and live normal lives.

'This is a first for patients with SCID-X1.'

Without treatment, children with bubble boy disease usually die when they're one or two because their body can't fight off even the simplest of infections.

The condition affects around one in 200,000 babies, mostly boys, and was brought into the public eye by a boy called David Vetter, who was born in Texas in 1971.

David could only have been cured by a bone marrow transplant but he died shortly after having one, when he was just 12 years old.

He spent his life living in protected environments – in a large tank or with a plastic bubble on his head to keep germs out – but he died of cancer in 1984.

His lymphoma was later found to have been caused by the Epstein-Barr virus, one of the most common human viruses and one which the immune system usually controls.

After the new treatment, which is combined with chemotherapy to help the edited DNA to multiply once inside the patient's body, most patients were able to leave the hospital within a month.

It has been tried on 10 children so far in Tennessee and UCSF Benioff Children's Hospital in San Francisco.

The results of eight patients were published in the New England Journal of Medicine and revealed they all now have working immune systems.

The therapy meant their bodies could, for the first time, create their own crucial white blood cells called T cells, B cells and natural killer (NK) cells.

It worked by scientists creating the gene required to fix sick patients' DNA in a lab, then injecting it into their bodies inside weakened HIV viruses.

Because HIV viruses are able to hijack DNA and spread through the body, this allowed the 'cured' genes to multiply and kick-start the immune system.

Once the genes had been delivered, the modified HIV viruses self-destructed inside the patient's blood.

All but one of the patients had working immune systems within three months of their first round of gene therapy – the final patient needed a second round before it succeeded.

Researcher Dr Mort Cowan said: 'While longer follow-up is needed to assess any late effects of treatment, these results suggest most patients treated with this gene therapy will develop a complete durable immune response without side effects.'

Omarion Jordan, who turns one later this month, had the therapy in December.

His mother, Kristin Simpson, said: 'For a long time we didn't know what was wrong with him. He just kept getting these infections.'

She said learning that he had SCID 'was just heartbreaking... I didn't know what was going to happen to him.'

Thanks to the therapy, Omarion now has a normal immune system.

'He's like a normal, healthy baby,' Ms Simpson said. 'I think it's amazing.'

Back to International News List


 

©Rutger Hauer Starfish Association 1999-2019
Terms of use - Disclaimer